Fertility, IVF, and GLP-1s in 2026: Timing, Pre-Conception Planning, and the PCOS Connection
For patients trying to conceive, the GLP-1 conversation becomes specifically about timing. These medications are not used during pregnancy, and they affect fertility in ways that matter — sometimes helpfully, sometimes in ways that require planning. In 2026, reproductive endocrinologists and fertility clinics have integrated GLP-1 timing into their pre-conception counseling, and patients with PCOS, obesity, or diabetes facing fertility challenges are increasingly using these medications strategically before IVF cycles. This article walks through the timing and the considerations.
The Pregnancy Rule First
GLP-1 medications are not used during pregnancy. The current 2026 guidance from reproductive endocrinologists and obstetricians is consistent: stop the medication at least two months before trying to conceive. Two months accounts for the washout period of the long-acting formulations and provides some margin for metabolic stabilization before conception. Some clinicians recommend longer washouts, particularly for patients with underlying diabetes who need time to establish a non-GLP-1 management plan. This is not a decision to improvise. It's a planned transition.
PCOS, Weight Loss, and Ovulation Return
For patients with PCOS — a major cause of infertility — GLP-1 therapy often restores ovulation that hadn't been reliably happening for years. The mechanism is insulin sensitivity improvement and weight reduction, both of which address the hormonal disruption at the center of PCOS. This is usually a welcome effect, but it can also produce unplanned pregnancies in patients who assumed their irregular cycles meant low fertility. In 2026, reliable contraception is a routine part of the GLP-1 conversation for any patient of reproductive age unless they're actively trying to conceive.
The Pre-Conception Strategy
For patients pursuing pregnancy after a period of GLP-1 therapy, the pre-conception picture often improves significantly. Weight loss before conception reduces risks of gestational diabetes, preeclampsia, birth defects, and delivery complications. Improved insulin sensitivity extends into early pregnancy. The 2026 approach at many fertility clinics is to use GLP-1 therapy deliberately to improve metabolic baseline, discontinue the medication two to three months before conception attempts or IVF cycles, and then monitor closely during the transition. Pregnancy outcomes in this approach have been encouraging.
IVF Cycles and Medication Timing
For patients pursuing IVF, the GLP-1 timing conversation becomes part of the broader IVF medication plan. Fertility specialists in 2026 generally want GLP-1s discontinued before ovarian stimulation begins — the nausea and gastric effects overlap poorly with IVF medication regimens, and the pregnancy consideration becomes more immediate. Patients with PCOS pursuing IVF often see improved cycle outcomes when GLP-1 therapy has been used strategically in the months before stimulation, a pattern that's become more studied as GLP-1 use has grown in the fertility population.
Male Fertility: An Underexplored Question
The GLP-1 and male fertility conversation is less developed than the female side, but not irrelevant. Obesity and metabolic syndrome affect testosterone, sperm count, and sperm quality, and GLP-1-driven weight loss generally improves these parameters. For couples where male factor infertility is part of the picture, the male partner's metabolic health is worth addressing alongside the female partner's. The 2026 fertility literature is beginning to treat both partners' health as shared territory, which is a significant shift from the female-focused framing that dominated for decades.
Talking With a Clinician You Trust
No article can replace a conversation with a licensed clinician who knows your history, your medications, and your goals. GLP-1 medications in 2026 are powerful and well-studied, but how they fit into your life is a personal question. The right provider will listen, explain the tradeoffs honestly, and help you build a plan that accounts for your whole health picture — not just the number on the scale.